We are live on ! Find out more
CRBU icon

Caribou Biosciences
CRBU

144 hedge funds and large institutions have $402M invested in Caribou Biosciences in 2023 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 55 increasing their positions, 31 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 12

77% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 31

71% more call options, than puts

Call options by funds: $544K | Put options by funds: $319K

19% more capital invested

Capital invested by funds: $338M → $402M (+$63.7M)

14% more funds holding

Funds holding: 126 → 144 (+18)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.8% less ownership

Funds ownership: 80.17% → 79.37% (-0.8%)

Holders
144
Holders Change
+18
Holders Change %
+14.29%
% of All Funds
2.1%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
30
Increased
55
Reduced
31
Closed
12
Calls
$544K
Puts
$319K
Net Calls
+$225K
Net Calls Change
-$27K

Top Buyers

Rank Fund Capital Flow
1
Alkeon Capital Management
Alkeon Capital Management
New York
+$7.26M
2
BlackRock
BlackRock
New York
+$4.86M
3
CS
Candriam SCA
Luxembourg
+$4.25M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$3.74M
5
WP
Woodline Partners
California
+$3.36M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$16.7M
2
RCMU
Rokos Capital Management (UK)
United Kingdom
-$9.43M
3
Pictet Asset Management
Pictet Asset Management
Switzerland
-$4.89M
4
Bank of America
Bank of America
North Carolina
-$3.53M
5
Walleye Capital
Walleye Capital
New York
-$2.24M
Name Holding Trade Value Shares
Change 		Change in
Stake
MC
26
Maverick Capital
Texas
$3.74M – – –
JP Morgan Chase
27
JP Morgan Chase
New York
$3.31M +$22.8K +4,606 +0.8%
Two Sigma Investments
28
Two Sigma Investments
New York
$2.89M +$1.52M +307,984 +157%
7IH
29
72 Investment Holdings
Connecticut
$2.72M – – –
Rafferty Asset Management
30
Rafferty Asset Management
New York
$2.18M -$624K -126,202 -25%
UBS Group
31
UBS Group
Switzerland
$1.87M +$865K +175,023 +116%
Wellington Management Group
32
Wellington Management Group
Massachusetts
$1.8M +$568K +114,975 +58%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$1.69M +$153K +30,991 +12%
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$1.62M +$1.24M +249,997 +783%
WHG
35
Westwood Holdings Group
Texas
$1.59M +$617K +124,769 +82%
N
36
Nuveen
North Carolina
$1.53M +$92.4K +18,695 +8%
Barclays
37
Barclays
United Kingdom
$1.51M +$45.7K +9,240 +4%
RA
38
Royce & Associates
New York
$1.45M +$1.13M +228,787 +941%
Adage Capital Partners
39
Adage Capital Partners
Massachusetts
$1.17M -$247K -50,000 -20%
BC
40
Bruce & Co
Illinois
$1.15M – – –
LCM
41
Laurion Capital Management
New York
$1.1M +$134K +27,159 +16%
RCA
42
Resonant Capital Advisors
Wisconsin
$1.06M +$911K +184,198 New
Aberdeen Group
43
Aberdeen Group
United Kingdom
$1.04M +$897K +181,487 New
Mirae Asset Global Investments
44
Mirae Asset Global Investments
South Korea
$995K -$585K -118,285 -41%
Citigroup
45
Citigroup
New York
$927K -$294K -59,447 -27%
AI
46
Atom Investors
Texas
$921K +$184K +37,234 +30%
Acadian Asset Management
47
Acadian Asset Management
Massachusetts
$826K +$713K +144,317 New
PAMP
48
Polar Asset Management Partners
Ontario, Canada
$798K +$689K +139,300 New
GIM
49
Granahan Investment Management
Massachusetts
$793K +$9.65K +1,952 +1%
DekaBank Deutsche Girozentrale
50
DekaBank Deutsche Girozentrale
Germany
$764K +$643K +130,000 New
1
2
3 4 5

CRBU Hedge Fund Activity: Q4 2023 in Review

144 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Caribou Biosciences (CRBU) for Q4 2023, worth a combined $402M — up 19% from $338M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new CRBU positions and 12 closed out — a net gain of 18 holders — while 55 added to existing stakes and 31 trimmed.

The largest buyer was Alkeon Capital Management, adding an estimated $7.26M. The largest seller was Deerfield Management, exiting entirely with an estimated $16.7M sold.

  • 144 institutional investors held Caribou Biosciences (CRBU) as of Q4 2023, up from 126 in Q3 2023.
  • Funds reported $402M of Caribou Biosciences stock for Q4 2023, up 19% quarter-over-quarter.
  • 30 funds opened new Caribou Biosciences positions in Q4 2023 and 12 closed out, a net change of +18 holders.
  • The largest Caribou Biosciences buyer in Q4 2023 was Alkeon Capital Management, an estimated $7.26M added.
  • The largest Caribou Biosciences seller in Q4 2023 was Deerfield Management, an estimated $16.7M sold.

Based on aggregated 13F filings for Q4 2023.